Abstracts tagged "Biologic agents and uveitis"

Abstract Number: 3041 • 2015 ACR/ARHP Annual Meeting
Long Term Biological Therapy in Uveitis Refractory Due to Behçet’s Disease. Multicenter Study of 165 Patients.
Montserrat Santos-Gómez¹, Vanesa Calvo-Río¹, Ricardo Blanco¹, Emma Beltran², Juan Sánchez Bursón Sr.³, Marina Mesquida⁴, Alfredo Adan⁴, M. Victoria Hernández⁵, F.Javier López-Longo⁶, Marisa Hernandez Grafella⁷, Elia Valls Pascual⁸, Lucía Martinez-Costa⁹, Agusti Sellas-Fernandez¹⁰, Miguel Cordero¹¹, Manuel Díaz-Llopis¹², Roberto Gallego¹³, Jose L. García Serrano¹⁴, JL Callejas Rubio¹⁵, Norberto Ortego-Centeno¹⁶, Jose M Herreras¹⁷, Alejandro Fonollosa¹⁸, Angel M. Garcia-Aparicio¹⁹, Olga Maiz Alonso²⁰, Ana Blanco²¹, Ignacio Torre²², Cruz Fernández- Espartero²³, Vega Jovani²⁴, Diana Peiteado²⁵, David Diaz Valle²⁶, Esperanza Pato²⁶, Juan Cruz²⁷, Carlos Férnandez Cid²⁸, Elena Aurrecoechea²⁹, Miriam García-Arias³⁰, Miguel Angel Caracuel-Ruiz³¹, Carlos Alberto Montilla Morales³², Antonio Atanes-Sandoval³³, Félix Francisco³⁴, Santos Insua³⁵, Senen González-Suárez³⁶, Amalia Sánchez-Andrade³⁷, Fernando Gamero³⁸, Luis Francisco Linares³⁹, Fredeswinda Romero⁴⁰, A. Javier García-González⁴¹, Raquel Almodóvar González⁴², Enrique Minguez⁴³, Carmen Carrasco Cubero⁴⁴, Alejandro Olivé⁴⁵, Julio Vázquez⁴⁶, Oscar Ruiz Moreno⁴⁷, Fernando Jiménez-Zorzo⁴⁸, Javier Manero⁴⁸, Santiago MuÑoz Fernandez⁴⁹, Cristina Fernández-Carballido⁵⁰, Esteban Rubio Romero⁵¹, Fred Antón Pagés⁵², Javier Toyos-Saenz de Miera⁵³, Myriam Gandía⁵⁴, Carmen Gonzalez-Vela⁵⁵, Enrique Raya⁵⁶, Natalia Palmou¹, Leyre Riancho-Zarrabeitia¹ and Miguel Angel Gonzalez-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ²Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain, ³Rheumatology, Hospital de Valme., Sevilla, Spain, ⁴Ophthalmology, Hospital Clinic, Barcelona, Spain, ⁵Arthritis Unit, Rheumatology, Hospital Clinic, Barcelona, Spain, ⁶Hospital Gregorio Marañón, Madrid, Spain, ⁷Ophthalmology., Hospital General Universitario de Valencia, Valencia, Spain, ⁸Rheumatology, Hospital Universitario Dr Peset, Valencia, Spain, ⁹Ophthalmology, Hospital Universitario Dr Peset, Valencia, Spain, ¹⁰Rheumatology, Hospital Universitario Valle Hebron, Barcelona, Spain, ¹¹Ophthalmology, Hospital de León, León, Spain, ¹²Hospital Universitario La Fe, Valencia, Spain, ¹³Ophthalmology, Hospital Universitario La Fe, Valencia, Spain, ¹⁴Ophthalmology, Hospital Universitario San Cecilio, Granada, Spain, ¹⁵Hospital Universitario San Cecilio, Granada, Spain, ¹⁶Systemic Autoimmune Diseases Unit, Hospital Universitario San Cecilio, Granada, Spain, ¹⁷Ophthalmology, Hospital Universitario, IOBA, Valladolid, Spain, ¹⁸Ophtalmology, Hospital de Cruces, Bilbao, Spain, ¹⁹Rheumatology, Hospital Virgen de la Salud, Toledo, Spain, ²⁰Rheumatology, Donostia University Hospital, Donostia, Spain, ²¹Ophthalmology, Donostia University Hospital, Donostia, Spain, ²²Rheumatology, Hospital de Basurto, Bilbao, Spain, ²³Rheumatology, Hospital La Zarzuela, Madrid, Spain, ²⁴Rheumatology, Hospital General de Alicante, Alicante, Spain, ²⁵Rheumatology, Hospital La Paz, Madrid, Spain, ²⁶Hospital Clínico San Carlos, Madrid, Spain, ²⁷Rheumatology, Hospital de Pontevedra, Pontevedra, Spain, ²⁸Ophthalmology, Hospital de Pontevedra, Pontevedra, Spain, ²⁹Rheumatology, Hospital de Sierrallana, Torrelavega, Spain, ³⁰Rheumatology, Hospital La Princesa, Madrid, Spain, ³¹Plaza Cruz Roja, 1, Hospital Reina Sofia, Córdoba, Spain, ³²Rheumatology, Hospital Universitario de Salamanca, Salamanca, Spain, ³³Rheumatology, Complejo Hospitalario Universitario de La Coruña, La Coruña, Spain, ³⁴Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain, ³⁵Rheumatology, Hospital Universitario Santiago de Compostela, La Coruña, Spain, ³⁶Rheumatology, Hospital de Cabueñes, Gijón, Spain, ³⁷Hospital Lucus Augusti, Lugo, Spain, ³⁸Rheumatology, Hospital San Pedro Alcántara, Cáceres, Spain, ³⁹Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain, ⁴⁰Section for Autoimmune Diseases, Rheumatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, ⁴¹Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ⁴²Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, ⁴³Ophthalmology., Hospital Clínico de Zaragoza, Zaragoza, Spain, ⁴⁴Rheumatology, Hospital de Mérida, Mérida, Spain, ⁴⁵Hospital Germans Trias i Pujol, Badalona, Spain, ⁴⁶Rheumatology., Hospital de Ferrol, La Coruña, Spain, ⁴⁷Ophthalmology and Rheumatology., Hospital Miguel Servet, Zaragoza, Spain, ⁴⁸Ophthalmology and Rheumatology, Hospital Miguel Servet, Zaragoza, Spain, ⁴⁹Rheumatology, Hospital Infanta Sofía, Madrid, Spain, ⁵⁰Rheumatology, Hospital General Universitario de Elda, Elda (Alicante), Spain, ⁵¹Rheumatology Department,, Hospital Universitario Virgen del Rocío, Sevilla, Spain, ⁵²Rheumatology, Hospital de Palencia, Palencia, Spain, ⁵³Rheumatology, Hospital Virgen de la Macarena, Seville, Spain, ⁵⁴Department of Autoimmune Diseases, IDIBAPS, Hospital Clínic, Barcelona, Spain, ⁵⁵Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ⁵⁶Rheumatology, Hospital Universitario San Cecilio, Granada, Spain
Background/Purpose: Conventional management of uveitis due to Behçet’s disease (UBD) consists on conventional immunosuppressive drugs. However, UBD is often refractory requiring more intensive therapy.Our aim was…
Abstract Number: 1250 • 2014 ACR/ARHP Annual Meeting
Golimumab As an Alternative Therapy in Patients with Uveitis Refractory to Other Anti-TNFα Drugs. Multicenter Study of 29 Cases
Montserrat Santos-Gómez¹, Francisco Ortiz-Sanjuán¹, Ricardo Blanco¹, Joaquín Cañal Villanueva², Alfredo Adan³, Marina Mesquida³, M. Victoria Hernández⁴, Esteban Rubio Romero⁵, Angel M. Garcia-Aparicio⁶, Antonio Atanes⁷, Ignacio Torre Salaberri⁸, Félix Francisco⁹, Cruz Fernández- Espartero¹⁰, Natalia Palmou¹¹, Vanesa Calvo-Río¹, Javier Loricera¹, Juan Ventosa¹², Trinitario Pina Murcia¹³, Leyre Riancho-Zarrabeitia¹ and Miguel A. González-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ²Ophthalmology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ³Ophthalmology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁴Arthritis Unit, Department of Rheumatology, Hospital Clinic, Barcelona, Barcelona, Spain, ⁵Rheumatology, Hospital Universitario Virgen del Rocío. Sevilla. Spain, Sevilla, Spain, ⁶Rheumatology, Virgen de la Salud Hospital, Toledo, Spain, ⁷HUCA. La coruña. Spain, La Coruña, Spain, ⁸Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ⁹Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, ¹⁰Rheumatology, Hospital Universitario de Móstoles. Madrid. Spain, Madrid, Spain, ¹¹Complejo Hospitalario Universitario de Albacete. Spain, Albacete, Spain, ¹²Ophtalmology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ¹³Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain
Background/Purpose To evaluate the clinical response and safety of golimumab (GLM) in a series of patients with non-infectious uveitis refractory to other anti-TNFα drugs.Methods Multicenter study of…
Abstract Number: 2625 • 2013 ACR/ARHP Annual Meeting
Biologic Therapy In Refractory Uveitis Of Behcet’s Syndrome: Switching and Dose Modification. Multicenter Study Of 124 Patients
F. Ortiz-Sanjuán¹, Vanesa Calvo-Río², Ricardo Blanco³, Emma Beltrán⁴, Juan Sánchez-Bursón⁵, Marina Mesquida⁶, Alfredo M. Adan⁶, M Hernandez Grafella⁷, E Valls Pascual⁸, L Martínez-Costa⁹, A Sellas-Fernàndez¹⁰, Miguel Cordero-Coma¹¹, Manuel Diaz-llopis¹², David Salom¹², Jl García Serrano¹³, Norberto Ortego¹³, JM Herreras¹⁴, Alejandro Fonollosa¹⁵, A Aparicio¹⁶, O Maíz¹⁷, A Blanco¹⁸, I Torre¹⁹, Cruz Fernández-Espartero²⁰, V Jovani²¹, D Peitado-Lopez²², Esperanza Pato²³, J Cruz²⁴, J. Carlos Fernandez-Cid²⁵, Elena Aurrecoechea²⁶, M García²⁷, M Caracuel²⁸, Carlos Montilla²⁹, A Atanes³⁰, F Francisco³¹, S Insua³², S González-Suárez³³, A Sánchez-Andrade³⁴, F Gamero³⁵, Luis Linares³⁶, F Romero-Bueno³⁷, J García³⁸, AJ García González³⁹, Raquel Almodovar⁴⁰, E Minguez⁴¹, C Carrasco Cubero⁴², Alejandro Olivé Marqués⁴³, J Vázquez⁴⁴, O Ruiz Moreno⁴⁵, F Jimenez-Zorzo⁴⁵, J Manero⁴⁵, Javier Loricera² and Miguel Angel González-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, ²Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ³Hospital Marques de Valdecilla, Santander, Spain, ⁴Rheumatology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, ⁵Hospital de Valme. Sevilla, Sevilla, Spain, ⁶Ophthalmology, Hospital Clínic of Barcelona, Barcelona, Spain, ⁷Ophthalmology, Hospital General Universitario, Valencia, Valencia, Spain, ⁸Rheumatology, Hospital Peset Valencia, Valencia, Spain, ⁹Ophthalmology, Hospital Peset Valencia, Valencia, Spain, ¹⁰Rheumatology, Hospital Val d´Hebron. Barcelona, Barcelona, Spain, ¹¹Departament of Ophthalmology, Hospital de León, León, Spain, ¹²Department of Ophthalmology, Hospital Universitario La Fe de Valencia, Valencia, Spain, ¹³Hospital San Cecilio. Granada, Granada, Spain, ¹⁴Hospital Universitario, IOBA. Valladolid, Valladolid, Spain, ¹⁵Ophtalmology Service, Hospital de Cruces. Bilbao, Baracaldo, Spain, ¹⁶Rheumatology., Hospital de Toledo., Toledo, Spain, ¹⁷Rheumatology, Hospital Donosti San Sebastian, San Sebastián, Spain, ¹⁸Ophthalmology., Hospital Donosti San Sebastian, San Sebastián, Spain, ¹⁹Rheumatology., Hospital Basurto. Bilbao, Bilbao, Spain, ²⁰Servicio de Reumatología, Hospital Universitario de Móstoles. Madrid, Madrid, Spain, ²¹Rheumatology., Hospital General de Alicante., Alicante, Spain, ²²Rheumatology, Hospital Universitario La Paz Madrid, Madrid, Spain, ²³Rheumatology, Hospital Clínico San Carlos. Madrid, Madrid, Spain, ²⁴Rheumatology, Hospital de Pontevedra, Pontevedra, Spain, ²⁵Departament of Ophthalmology, Hospital de Pontevedra, Pontevedra, Spain, ²⁶Rheumatology, Hospital Sierrallana. Torrelavega, Torrelavega, Spain, ²⁷Rheumatology., Hospital La Princesa. Madrid, Madrid, Spain, ²⁸Rheumatology., Hospital de Córdoba., Córdoba, Spain, ²⁹Rheumatology Service, Hospital Universitario de Salamanca, Salamanca, Spain, ³⁰Rheumatology., HUCA La Coruña., A Coruña, Spain, ³¹Rheumatology., Hospital Doctor Negrín Canarias., Canarias, Spain, ³²Rheumatology., Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain, ³³Rheumatology., Hospital Cabueñes, Gijón, Gijón, Spain, ³⁴Rheumatology., Hospital Lucus Augusti Lugo, Lugo, Spain, ³⁵Rheumatology., Hospital San Pedro Alcantara Caceres, Caceres, Spain, ³⁶Rheumatology, Hospital Universitario Virgen de la Arrixaca. Murcia, Murcia, Spain, ³⁷Rheumatology., Fundación Jimenez Díaz. Madrid, Madrid, Spain, ³⁸Rheumatology, Hospital 12 de Octubre. Madrid, Madrid, Spain, ³⁹Rheumatology., Hospital 12 de Octubre. Madrid, Madrid, Spain, ⁴⁰Rheumatology Unit, Hospital Universitario Fundación Alcorcón. Madrid, Alcorcon. Madrid, Spain, ⁴¹Ophthalmology, Hospital Clínico de Zaragoza, Zaragoza, Spain, ⁴²Rheumatology., Hospital de Mérida, Mérida, Spain, ⁴³Hospital Germans Trias i Pujol. Badalona, Barcelona, Spain, ⁴⁴Rheumatology, Hospital de Ferrol. A Coruña, A Coruña, Spain, ⁴⁵Hospital Universitario Miguel Servet. Zaragoza, Zaragoza, Spain
Background/Purpose: Several situations can be observed in patients undergoing biologic therapy in uveitis associated to Behçet´s syndrome (BS): a) Patients are switched to another therapy…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].